![](/img/cover-not-exists.png)
P3-135: Results of an open-label, Phase II trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel), carboplatin, and bevacizumab as first-line therapy in patients with advanced non-squamous non-small cell lung cancer (NSCLC)
Reynolds, Craig, Barrera, David, Vu, Duy Quoc, Jotte, Robert, Spira, Alexander I., Weissman, Charles, Boehm, Kristi A., Pritchard, Sharon, Asmar, LinaVolume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000284110.26459.89
Date:
August, 2007
File:
PDF, 174 KB
english, 2007